Loading…
Q32 Bio Inc. is projected to rise to $13.92 by 2027, a +24% move from its current price of $11.21. QTTB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $10.49 | $11.21 | $11.99 | +0.03% |
| Jul 15 | $10.21 | $11.22 | $12.32 | +0.07% |
| Jul 16 | $10.00 | $11.22 | $12.59 | +0.10% |
| Jul 17 | $9.83 | $11.22 | $12.82 | +0.13% |
| Jul 18 | $9.68 | $11.23 | $13.03 | +0.16% |
| Jul 19 | $9.54 | $11.23 | $13.22 | +0.20% |
| Jul 20 | $9.42 | $11.24 | $13.40 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.42 | $11.24 | $13.40 | +0.23% |
| Week 2 | $8.78 | $11.26 | $14.45 | +0.46% |
| Week 3 | $8.32 | $11.29 | $15.31 | +0.69% |
| Week 4 | $7.96 | $11.31 | $16.09 | +0.92% |
| Week 5 | $7.65 | $11.34 | $16.81 | +1.16% |
| Week 6 | $7.38 | $11.37 | $17.49 | +1.39% |
| Week 7 | $7.15 | $11.39 | $18.15 | +1.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Q32 Bio Inc. is a clinical-stage biotechnology company in Healthcare that develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
The company is developing Bempikibart (ADX-914), a fully human anti-interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata.
It also develops ADX-096, a C3d mAb — CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. (QTTB) is a Healthcare stock currently trading at $11.21 per share, with a market capitalization of $190.08M. It is ranked 3861 among peers in the market.
Forecasts outline potential upside beyond the near term, with the 2026 average price at $11.21 and a 0% ROI, followed by rising averages: 2027 $13.89 (ROI 23.9), 2030 $18.40 (ROI 64.1), 2040 $57.93 (ROI 416.8), and 2050 $102.12 (ROI 811).
The forecast also lists a 2026 min of $3.33 and a max of $16.72, reflecting a broad near-term range, with a bullish bias emerging in the later years. The numbers imply meaningful upside through 2050, but should be viewed as estimates, not guarantees, given the high volatility embedded in the data (annualized volatility 100%).
A major floor 59.5% below — a decisive break under it would weaken the trend.
The nearest floor, 8.0% below — buyers have tended to step in here.
The nearest ceiling, 26.1% above — a clean break opens room to run.
A major ceiling 40.2% above — clearing it would confirm fresh momentum.
Key QTTB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QTTB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.87 | Sell | $12.51 | Sell |
| MA 10 | $13.01 | Sell | $12.69 | Sell |
| MA 20 | $12.68 | Sell | $12.38 | Sell |
| MA 50 | $9.92 | Buy | $10.61 | Buy |
| MA 100 | $7.84 | Buy | $8.58 | Buy |
| MA 200 | $5.45 | Buy | $7.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.24 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -177.69 | Sell |
| Williams %R (14) | -98.32 | Info |
| MACD (12,26,9) | -0.27 | Sell |
| ROC (12) | -5.64 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 1.68 | Buy |
| TRIX (15) | 1.23 | Buy |
| Awesome (5,34) | 0.92 | Buy |
| Ultimate (7,14,28) | 40.35 | Neutral |
| Momentum (10) | -0.74 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 12.80 | Sell |
| ADX (14) | 18.50 | Neutral |
| ATR (14) | 0.78 | Info |
The 30-day technical picture is bullish, with sentiment labeled as BULLISH overall.
Key momentum indicators show RSI14 at 50, while the simple moving averages sit at $9.92 for SMA50 and $5.45 for SMA200, indicating the stock is trading above long-term averages but near-term resistance and support levels.
Support is identified at $10.31 and resistance at $14.14, framing a near-term trading range. The 30-day price range spans from a low of $7.23 to a high of $17.38, underscoring considerable volatility in the short term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.33 | $11.21 | $16.67 | 0% | Neutral | |
| $10.10 | $13.92 | $20.74 | +24% | Bullish | |
| $9.35 | $13.69 | $21.74 | +22% | Bullish | |
| $8.91 | $13.75 | $22.92 | +23% | Bullish | |
| $11.39 | $18.42 | $31.97 | +64% | Bullish | |
| $13.00 | $21.97 | $39.46 | +96% | Bullish | |
| $15.82 | $27.88 | $51.65 | +149% | Bullish | |
| $18.92 | $34.73 | $66.12 | +210% | Bullish | |
| $16.97 | $32.41 | $63.26 | +189% | Bullish | |
| $17.08 | $33.92 | $67.74 | +203% | Bullish | |
| $26.09 | $57.98 | $127.28 | +417% | Bullish | |
| $45.82 | $101.82 | $234.19 | +808% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.33 | $11.21 | $13.14 | +0.00% |
| August 2026 | $8.91 | $10.79 | $13.60 | -3.73% |
| September 2026 | $9.41 | $11.55 | $14.87 | +7.04% |
| October 2026 | $9.37 | $11.65 | $15.26 | +0.88% |
| November 2026 | $9.20 | $11.55 | $15.35 | -0.84% |
| December 2026 | $9.76 | $12.38 | $16.67 | +7.15% |
Click any year to see its month-by-month QTTB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect QTTB to range from $3.33 to $16.67 through 2026. The $11.21 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The QTTB price prediction for 2027 points to an average of $13.92 (low $10.10, high $20.74) — a potential gain of +24% on today's $11.21. Buyers look set to stay in control over this stretch.
In 2028, QTTB is projected to trade between $9.35 and $21.74, averaging $13.69 — a potential gain of +22% from today's $11.21. That is -2% versus the projected 2027 average. Momentum favours further upside here.
Q32 Bio Inc.'s 2029 outlook centres on $13.75, within a $8.91 to $22.92 range. That is up 0% on the projected 2028 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, QTTB could reach as high as $31.97, with a base case around $18.42 and support toward $11.39 — roughly +64% from $11.21. Momentum favours further upside here.
Expect QTTB to range from $13.00 to $39.46 through 2031. The $21.97 average target implies a +96% move from current prices. That is up +19% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The QTTB price prediction for 2032 points to an average of $27.88 (low $15.82, high $51.65) — a potential gain of +149% on today's $11.21. Momentum favours further upside here.
In 2033, QTTB is projected to trade between $18.92 and $66.12, averaging $34.73 — a potential gain of +210% from today's $11.21. That is up +25% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Q32 Bio Inc.'s 2034 outlook centres on $32.41, within a $16.97 to $63.26 range. That is -7% versus the projected 2033 average. That marks a +189% change versus current levels. Momentum favours further upside here.
By 2035, QTTB could reach as high as $67.74, with a base case around $33.92 and support toward $17.08 — roughly +203% from $11.21. Buyers look set to stay in control over this stretch.
Expect QTTB to range from $26.09 to $127.28 through 2040. The $57.98 average target implies a +417% move from current prices. That is up +71% on the projected 2035 average. Momentum favours further upside here.
The QTTB price prediction for 2050 points to an average of $101.82 (low $45.82, high $234.19) — a potential gain of +808% on today's $11.21. Buyers look set to stay in control over this stretch.
Investing $1,000 in QTTB today (≈ 89.206066 QTTB) could be worth
$9,083.19
+$8,083.19 (+808%) by 2050 · US Dollar
Based on the average projected QTTB price of $101.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QTTBwould be worth at today's price.
$1,000 invested in QTTB on Jul 10, 2025 (≈ 301.204825 QTTB) would be worth
$3,376.51
+$2,376.51 (+237.7%) today · 3.38× · US Dollar
Based on a QTTB entry price of $3.32 vs. today's $11.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.09 | $856.38 | -14.4% |
| 1 month ago | $12.87 | $871.02 | -12.9% |
| 3 months ago | $5.05 | $2,219.8 | +122.0% |
| 6 months ago | $3.64 | $3,079.67 | +208.0% |
| 1 year ago | $3.32 | $3,376.51 | +237.7% |
| All time (5.0y) ago | $114.66 | $97.77 | -90.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QTTB forecast.
Our base-case forecast reaches $22.00 around 2032.
Implied market cap at $22.00: $373.04M
The multi-year outlook points to substantial upside across the coming decades. In 2027 the average price is forecast at $13.89 (ROI 23.9) and remains bullish into 2030 with an average of $18.40 (ROI 64.1).
By 2040, the average price is projected at $57.93 (ROI 416.8) and by 2050 at $102.12 (ROI 811), with a max forecast as high as $234.88 in 2050. The sentiment remains BULLISH across these years, signaling strong long-run upside despite near-term uncertainty.
These figures are estimates and not guarantees. The forecast also shows a wide near-term range (2026 min $3.33, max $16.72) and a high level of volatility (annualized volatility 100%), which underscores the potential for sizeable swings in price.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $18.40, with a minimum of $11.37 and a maximum of $31.93, representing an ROI of 64.1% and a bullish sentiment.
Forecasts show rising averages after 2026, with 2027 at $13.89 (ROI 23.9) and 2030 at $18.40 (ROI 64.1), culminating in 2050 at $102.12 (ROI 811) with bullish sentiment.
Yes. The 2050 forecast shows an average price of $102.12 and a max of $234.88, corresponding to an ROI of 811 and a bullish long-term outlook.
The current price is $11.21 and the market cap is $190.08M.
The 30-day range is $7.23 to $17.38, with a support of $10.31 and a resistance of $14.14.
Q32 Bio Inc. Community Discussion
0Share your Q32 Bio Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.